Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paul Valensi. (2009) Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 2, pages 61-71.
Read now
Read now
Yang Wenying, Marian Benroubi, Vito Borzi, Janusz Gumprecht, Ryuzo Kawamori, Joseph Shaban, Siddharth Shah, Marina Shestakova, Robert Ligthelm & Paul Valensi. (2009) Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Current Medical Research and Opinion 25:11, pages 2643-2654.
Read now
Read now
Mohammed Ali, Jeremy White, Chen-Hui Lee, James L Palmer, Jayne Smith-Palmer, Walid Fakhoury & William J Valentine. (2008) Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia. Journal of Medical Economics 11:4, pages 651-670.
Read now
Read now
Articles from other publishers (14)
Marcin Czech, Elżbieta Rdzanek, Justyna Pawęska, Olga Adamowicz-Sidor, Maciej Niewada & Michał Jakubczyk. (2015) Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis. BMC Endocrine Disorders 15:1.
Crossref
Crossref
Edoardo Mannucci, Matteo Monami, Ilaria Dicembrini, Attilio Piselli & Massimo Porta. (2014) Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis. Journal of Endocrinological Investigation 37:5, pages 477-495.
Crossref
Crossref
Elena Viktorovna Surkova. (2013) Ten years of NovoMix 30 in Russian and international clinical practice. Diabetes mellitus 16:4, pages 101-107.
Crossref
Crossref
Mohammad Ebrahim Khamseh, Jihad Haddad, Wenying Yang, Alexey Zilov, Ole Molskov Bech & Mohammad Imtiaz Hasan. (2013) Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis. Diabetes Therapy 4:2, pages 347-361.
Crossref
Crossref
Mary Hines & Katherine W. Lyseng-Williamson. (2013) Biphasic insulin aspart 30: a guide to its use in diabetes mellitus. Drugs & Therapy Perspectives 29:5, pages 135-140.
Crossref
Crossref
N. El-Naggar, A. Almansari, K. Khudada, S. Salman, N. Mariswamy, W. AbdelFattah & F. Hashim. (2013)
The A
1
chieve study - an observational non-interventional study of patients with type 2 diabetes mellitus initiating or switched to insulin analogue therapy: subgroup analysis of the Gulf population
. International Journal of Clinical Practice 67:2, pages 128-138.
Crossref
Crossref
Hye Jin YooKeun Yong ParkKang Seo ParkKyu Jeung AhnKyung Wan MinJeong Hyun ParkSang Ah ChangBong Soo ChaDong-Jun KimYong Seong KimTae Keun OhSuk ChonIl Seong Nam-GoongMi Jin KimHye-Soon KimYoung Sik ChoiYou Hern AhnSora LeeSei Hyun Baik. (2013) Safety and Efficacy of Modern Insulin Analogues. Diabetes & Metabolism Journal 37:3, pages 181.
Crossref
Crossref
Andreas Liebl, Vinay Prusty, Paul Valensi, Ryuzo Kawamori, Jens Sandahl Christiansen, Andrew J. Palmer, Per Balschmidt, Robert Ligthelm & Viswanathan Mohan. (2012) Ten Years of Experience with Biphasic Insulin Aspart 30. Drugs 72:11, pages 1495-1520.
Crossref
Crossref
Philip Home, Nabil El Naggar, Mohammed Khamseh, Guillermo Gonzalez-Galvez, Chunduo Shen, Praful Chakkarwar & Yang Wenying. (2011) An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study. Diabetes Research and Clinical Practice 94:3, pages 352-363.
Crossref
Crossref
Kyoung Hee Lee, Se Jin Seo, Jayne Smith-Palmer, James L. Palmer, Jeremy White & William J. Valentine. (2009) Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea. Value in Health 12, pages S55-S61.
Crossref
Crossref
N. Yoshioka, Y. Kurihara, N. Manda, K. Komori, M. Kato, H. Kijima, N. Wada, K. Yanagisawa, S. Aoki, Y. Ono & T. Koike. (2009) Step-up therapy with biphasic insulin aspart-70/30—Sapporo 1-2-3 study. Diabetes Research and Clinical Practice 85:1, pages 47-52.
Crossref
Crossref
Surendra K. Sharma, Jing Ping Yeo & Alan Garber. (2008) Lessons in initiating insulin in clinical practice. Diabetes Research and Clinical Practice 81, pages S16-S22.
Crossref
Crossref
Andreas Liebl. (2008) The PRESENT study: Helping to put clinical trials into clinical practice. Diabetes Research and Clinical Practice 81, pages S1-S2.
Crossref
Crossref
James L. Palmer, Meaghan Gibbs, Huib WKFH Scheijbeler, Robert W. Kotchie, Steffen Nielsen, Jeremy White & William J. Valentine. (2008) Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China. Advances in Therapy 25:8, pages 752-774.
Crossref
Crossref